Results 271 to 280 of about 441,815 (305)

The proteolytic activation of interleukin-1 beta.

Agents and actions. Supplements, 1992
Interleukin-1 beta (IL-1 beta) is released from an inactive precursor by a proteolytic cleavage. A monocytic protease has been identified that appears to be involved in the physiological activation of this cytokine. Two situations have been found in which precursor IL-1 beta exists without the monocytic processing enzyme, and in these cases other ...
R, Black, S, Kronheim, P, Sleath, T, Greenstreet, G D, Virca, C, March, T, Kupper   +6 more
openaire   +1 more source

Pro-interleukin-1 beta and mature interleukin-1 beta in human trophoblast

American Journal of Obstetrics and Gynecology, 1997
I.M. Vettraino, D.M. Nelson, D.D. Chaplin   +2 more
openaire   +1 more source

Interleukin-1 Beta

2020
openaire   +1 more source

Anakinra/interleukin 1 beta inhibitors/tocilizumab

Reactions Weekly, 2023
openaire   +1 more source

Role of interleukin 1-beta in meningeal inflammation

The Pediatric Infectious Disease Journal, 1989
O, Ramilo, M M, Mustafa, X, Sáez-Llorens, J, Mertsola, S, Ohkawara, M, Yoshinaga, E J, Hansen, G H, McCracken   +7 more
openaire   +2 more sources

Interleukin-1, interleukin-1-beta

2006
openaire   +1 more source

Interleukin-1, interleukin-1-beta

2011
openaire   +1 more source

Interleukin-1 beta

2011
openaire   +1 more source

Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus

New England Journal of Medicine, 2007
Allan Vaag, Burkhardt Seifert, Thomas Mandrup-Poulsen   +2 more
exaly  

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

Lancet Oncology, The, 2018
Ruth Ladenstein, Ulrike Pötschger, Roberto Luksch   +2 more
exaly